NCT02195986 - A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis | Biotech Hunter

Enrollment

366

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Atrophic Vaginitis

Interventions

DRUG

Estradiol Vaginal Cream, 0.01%

Estradiol Vaginal Cream, 0.01% (1 x 2g for 7 days)

DRUG

Estrace® 0.01% cream

Estrace® 0.01% vaginal cream ( 1 x 2g for 7 days)

DRUG

Placebo Vaginal Cream

Placebo Vaginal Cream ( 1 x 2 g for 7 days)

Trial Locations (21)

30312

Georgia Center for Women, Atlanta

33014

Veritas Research, Corp., Miami Lakes

33065

Sunrise Medical Research, Coral Springs

33136

SouthCoast Research Center, Miami

33351

Sunrise Medical Research, Tamarac

33409

Comprehensive Clinical Trials, LLC, West Palm Beach

33458

Health Awareness, Inc., Jupiter

33709

Meridien Research, St. Petersburg

33805

Meridien Research, Lakeland

34239

Physician Care Clinical Research LLC, Sarasota

34748

OB-GYN Associates of Mid Florida, Leesburg

80209

Downtown Women's Health Care, Denver

80220

Horizons Clinical Research Center, LLC, Denver

80910

MCB Clinical Research Centers, Colorado Springs

85712

ARA-Arizona Research Associates, Tucson

90036

Axis Clinical Trials, Los Angeles

92108

MCCR, San Diego

92123

Women's Health Care Research Corp., San Diego

95821

Northern CA Research, Sacramento

08690

Lawrence OB/GYN Clinical Research, LLC, Lawrenceville

08536

Women's Health Research Center/The Center for Women's Health & Wellness, LLC, Plainsboro